Urology · Elgin, IL
NPI
1225055866
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
745 Fletcher Dr Ste 301
Elgin, IL, 60123
Phone (847) 741-0398
Groups this clinician bills Medicare through
Medicare paid, 2024
$390K
16,480 services
Medicare patients, 2024
1,021
Average age 76
Drug cost, 2024
$233K
3,263 prescriptions
Company payments, 2025
$860
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jae H Kim was code J0585 (injection, onabotulinumtoxina, 1 unit), 7,500 times for 27 patients. In total Jae H Kim billed 16,480 services in 91 codes, and Medicare paid $390K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 7,500 | 27 | $4.81 | $36K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,363 | 796 | $13.55 | $18K |
| 81003 Clinical Chemistry | Office | 1,356 | 773 | $2.19 | $2,972 |
| 99214 Office E&M - Established | Office | 1,198 | 715 | $102.87 | $123K |
| 51798 Ultrasound - Nonspecific | Office | 932 | 605 | $9.27 | $8,637 |
| 52000 Cystourethroscopy | Office | 176 | 119 | $188.84 | $33K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 171 | 43 | $53.22 | $9,101 |
| 99213 Office E&M - Established | Office | 125 | 115 | $75.29 | $9,412 |
| 99204 Office E&M - New | Office | 103 | 103 | $135.53 | $14K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 80 | 32 | $42.01 | $3,361 |
| 99215 Office E&M - Established | Office | 80 | 72 | $137.36 | $11K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 68 | 14 | $0.36 | $24.76 |
| 51702 Other Organ Systems | Office | 56 | 27 | $50.08 | $2,805 |
| 51784 Neurologic | Office | 39 | 38 | $28.29 | $1,103 |
| 52287 Cystourethroscopy | Office | 36 | 27 | $339.35 | $12K |
By year: 2022 $456K for 14,990 services; 2023 $403K for 11,483 services; 2024 $390K for 16,480 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,356 | 773 | $2.19 | $2,972 |
Medicare prescription drug claims, 2024
In 2024, the drug Jae H Kim prescribed most often to Medicare patients was Solifenacin Succinate, with 976 prescriptions and refills. In total Jae H Kim wrote 3,263 Medicare prescriptions that cost $233K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Solifenacin Succinate Generic | 976 | 1,972 | 278 | $41K |
| Tamsulosin Hcl Generic | 567 | 1,447 | 174 | $11K |
| Trospium Chloride Generic | 243 | 500 | 79 | $16K |
| Finasteride Generic | 221 | 626 | 67 | $3,154 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 154 | 261 | 73 | $4,455 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 139 | 285 | 37 | $8,387 |
| Cephalexin Generic | 127 | 131 | 109 | $782 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 96 | 228 | 36 | $2,026 |
| Trimethoprim Generic | 76 | 131 | 21 | $3,492 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 72 | 72 | 66 | $257 |
| Gemtesa Vibegron | 72 | 122 | 21 | $55K |
| Myrbetriq Mirabegron | 66 | 130 | 22 | $63K |
| Estradiol Generic | 50 | 134 | 28 | $3,363 |
| Testosterone Generic | 24 | 39 | Under 11 | $2,667 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 23 | 45 | Under 11 | $424 |
Brand drugs: 260 claims; generic drugs: 3,003 claims; opioid claims: 91.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jae H Kim $860 ($860 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $316.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 13 | $316 |
| Sumitomo Pharma America, Inc. 4506.T | 17 | $160 |
| Pfizer Inc. PFE | 6 | $137 |
| Urogen Pharma, Inc. URGN | 3 | $79.64 |
| Olympus America Inc. | 2 | $52.36 |
| Progenics Pharmaceuticals, Inc. | 2 | $45.51 |
| Janssen Biotech, Inc. JNJ | 1 | $24.75 |
| Coloplast Corp | 1 | $16.44 |
| Endo USA, Inc. | 1 | $14.5 |
| Boston Scientific Corporation BSX | 1 | $13.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.